ResMed, ATS support research on remote monitoring for COPD patients
By HME News Staff
Updated Tue February 4, 2020
SAN DIEGO - ResMed and the ATS Foundation have awarded their third $100,000 research fellowship grant to Claude Farah, PhD, of the Woolcock Institute of Medical Research in Sydney, Australia, to study how remote monitoring can help improve the management of COPD patients. The aim of the study: to detect early changes in lung function from daily recordings and notify patients when to commence more intensive treatment or seek medical attention. In his application for the grant, Farah predicts, “This intervention will reduce the chance of patients needing hospitalization for these lung attacks.” “This grant is important as it tests how integration of technology that enables convenient at-home remote monitoring of patients' lung function helps with earlier detection and interventions of COPD exacerbations, aiming to prevent further deterioration in their condition,” said Mihaela Teodorescu, MD, MS, chair of the ATS Assembly on Sleep and Respiratory Neurobiology. ResMed markedly increased its presence in the oxygen market in 2018, buying Propeller Health, a company that provides connected health solutions for people living with COPD and asthma, for $225 million, and launching its first portable oxygen concentrator, the Mobi.
Comments